Loss of mTAP expression was observed in five (of 34, 14.7%) thymic carcinomas, including three squamous cell carcinomas (Figure 1D–F), one sarcomatoid carcinoma, and one adenosquamous carcinoma. Here, MTAP is linked to sarcomatoid carcinoma.